EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During Aging

Daiki Kojima, Keisuke Yaku, Shotaro Kosugi, Ryunosuke Mitsuno, Kenji Kaneko, Yoshinaga Kawano, Akihito Hishikawa, Seiya Mizuno iD, Manami Katoh, Akiko Satoh, Shinya Toyokuni, Tatsuhiko Azegami iD und 8 weitere

Aging Cell · 2026-05 · 25 (5)

DOI: 10.1111/acel.70509 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 21.04.2026. Verfasst von Daiki Kojima und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Aging, Adipocytes, Mitochondria, Adipose Tissue. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Naito Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nicotinamide adenine dinucleotide (NAD) is a classical coenzyme regulating cellular energy metabolism. Emerging evidence demonstrates the causal relationship between defective NAD metabolism and various age‐associated diseases. The major purpose of the present study was to investigate the role of adipocyte mitochondrial NAD biology in age‐associated metabolic diseases. To this end, we focused on solute carrier family 25 member 51 (SLC25A51), a recently identified mitochondrial NAD transporter. We found that aging was associated with decreased adipose tissue SLC25A51 expression in both humans and mice. We next generated and analyzed novel knockout and overexpression models, which we have named adipocyte‐specific Slc25a51 knockout (ASKO) and Slc25a51 overexpressing (ASLO) mice. ASKO mice had a marked decrease in adipose tissue mitochondrial NAD levels and exhibited age‐associated systemic metabolic complications, such as obesity, glucose intolerance, insulin resistance, hyperinsulinemia, metabolic inflexibility, dyslipidemia, and hepatosteatosis. Mechanistically, loss of Slc25a51 reduced mitochondrial respiratory function, fatty acid oxidation capacity, and adiponectin production in adipose tissue, likely contributing to the development of systemic metabolic complications. Conversely, ASLO mice were protected from obesity and insulin resistance caused by aging. In conclusion, our results provide novel mechanistic and therapeutic insights into understanding the critical role of adipocyte mitochondrial NAD transporter SLC25A51 in the pathophysiology of age‐associated metabolic diseases, particularly obesity and insulin resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AgingAdipocytesMitochondriaAdipose TissueNADAnimalsMiceHumansMice, KnockoutInsulin ResistanceMaleMice, Inbred C57BL

Stichwörter der Autor:innen

NADadipocyteaginginsulin resistanceobesity

Substanzen

NAD

Autor:innen und Institutionen

  • Division of Endocrinology, Metabolism and Nephrology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
  • Department of Molecular and Medical Pharmacology, Faculty of Medicine, University of Toyama, Toyama, Japan.
  • Laboratory Animal Resource Center in Transborder Medical Research Center, Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  • Departments of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Frontier Cardiovascular Science, The University of Tokyo, Tokyo, Japan.
  • Department of Integrative Physiology, Division of Brain Science, Institute of Development, Aging and Cancer (IDAC), Tohoku University, Sendai, Japan.

ORCID-Profile: Seiya Mizuno, Tatsuhiko Azegami, Shintaro Yamaguchi, Toshimasa Yamauchi, Jun Yoshino

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Naito Foundation
  • Novo Nordisk Pharma
  • Astellas
  • Japan Geriatrics Society
  • Salt Science Research Foundation
  • Keio University Program for the Advancement of Next Generation Research Projects

Zitieren

APA

Kojima, D., Yaku, K., Kosugi, S., Mitsuno, R., Kaneko, K., Kawano, Y., Hishikawa, A., Mizuno, S., Katoh, M., Satoh, A., Toyokuni, S., Azegami, T., Kinouchi, K., Yamaguchi, S., Itoh, H., Kanda, T., Yamauchi, T., Nakagawa, T., Hayashi, K., & Yoshino, J. (2026). The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During Aging. Aging Cell, 25(5). https://doi.org/10.1111/acel.70509

Vancouver

Kojima D, Yaku K, Kosugi S, Mitsuno R, Kaneko K, Kawano Y, et al. The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During Aging. Aging Cell. 2026;25(5). doi:10.1111/acel.70509

BibTeX
@article{Kojima2026,
  author = {Kojima, Daiki and Yaku, Keisuke and Kosugi, Shotaro and Mitsuno, Ryunosuke and Kaneko, Kenji and Kawano, Yoshinaga and Hishikawa, Akihito and Mizuno, Seiya and Katoh, Manami and Satoh, Akiko and Toyokuni, Shinya and Azegami, Tatsuhiko and Kinouchi, Kenichiro and Yamaguchi, Shintaro and Itoh, Hiroshi and Kanda, Takeshi and Yamauchi, Toshimasa and Nakagawa, Takashi and Hayashi, Kaori and Yoshino, Jun},
  title = {The Mitochondrial NAD Transporter SLC25A51 in Adipocytes Regulates Adipose Tissue Mitochondrial Function and Systemic Metabolism During Aging},
  journal = {Aging Cell},
  year = {2026},
  volume = {25},
  number = {5},
  doi = {10.1111/acel.70509}
}
Kostenlos starten →